AMS Planning
PrivateLast Round
Private Equity
May 30, 2025
Total Funding Raised
$2M
Company Overview
AMS Planning is a drug discovery company that develops nuclear medicine technologies designed to transform Japan's healthcare infrastructure by advancing clinical innovation and operational efficiency.
Sector
Media, Entertainment & Gaming
Verticals
Facility Management, HR, Project Management
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMS Planning Comps
Public and private peers based on sector, stage, and business model.
AMS Planning Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 30, 2025 | ||||
| Series A | Nov 9, 2022 |
AMS Planning Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIRAISOZO INVESTMENTS Inc. | Series A, Private Equity |
| Vision Incubate Co., Ltd. | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors grew 367% MoM, from 364 to 1.7K.
- May 30, 2025
$1M round led by MIRAISOZO INVESTMENTS Inc.
AMS Planning Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AMS Planning's valuation, stock price, and market status.
